🇺🇸 FDA
Patent

US 8288359

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

granted A61KA61K31/7088A61K38/00

Quick answer

US patent 8288359 (Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7088, A61K38/00, A61K45/06, A61P